The United States Food and Drug Administration (FDA) sets the world's most rigorous, science-based standards for pharmaceutical products, medical devices, and healthcare technologies. With unparalleled market opportunities comes equally demanding regulatory requirements.
Navigating FDA compliance requires deep expertise across multiple pathways including INDs, NDAs, BLAs, 510(k), PMAs, and De Novo submissions. Our experienced team specializes in:
MedWisdom LifeScience is your strategic partner in achieving FDA approval and maintaining long-term regulatory compliance in the world's most competitive and rewarding pharmaceutical market.
We deliver end-to-end regulatory support tailored to your product type, development stage, and market goals. Our solutions accelerate approvals while ensuring full FDA compliance.
Expert preparation of FDA-compliant eCTD (electronic Common Technical Document) files for NDAs, BLAs, and investigational new drug submissions. We ensure complete technical accuracy, regulatory compliance, and optimized presentation to FDA reviewers for faster approvals.
Navigate the investigational new drug pathway with confidence. We provide IND/CTN submissions, Pre-IND meeting preparation, protocol development support, and ongoing clinical trial regulatory compliance through all phases of drug development.
Strategic guidance and complete submission support for New Drug Applications, Abbreviated New Drug Applications, and Biologics License Applications. Our expertise ensures optimal dossier structure and expedited FDA review pathways.
Streamlined 510(k) submissions for medical devices with predicate devices. We assess classification, determine substantial equivalence, and optimize submission strategies for rapid market clearance and compliance.
Full support for FDA cGMP compliance, quality system implementation, regulatory inspections, and CAPA management. Our QA/QC expertise ensures your manufacturing processes meet FDA's most stringent standards.
Comprehensive drug safety programs including QPPV support, adverse event reporting (FAERS), IND safety reports, and post-market surveillance plans. We ensure ongoing compliance with FDA safety requirements throughout product lifecycle.
Expert preparation for critical FDA interactions including Pre-Submission, Type A/B/C meetings, and End-of-Phase meetings. We position your product strategically to accelerate approvals and address regulatory concerns proactively.
Development of ISO 14971-compliant risk management files, hazard analysis, and FDA-aligned risk mitigation strategies. Our assessments ensure product safety, efficacy, and regulatory compliance from development through commercialization.
Strategic support for Fast Track designation, Breakthrough Therapy status, and Priority Review qualification. We maximize your product's competitive advantages and accelerate time-to-market in the US.
Expert guidance on CMC changes, manufacturing changes, and regulatory variations (CBE, PIND submissions). We ensure compliance with FDA amendment procedures while maintaining product quality and market stability.
Customized FDA compliance training programs covering 21 CFR Parts 11, 210, 211, 820, 803, and 806. We equip your teams with essential regulatory knowledge for sustained US market success.
Professional medical writing for regulatory submissions, clinical study reports, safety updates, and technical documents. Our writers ensure clear, compelling narratives that address FDA expectations and support approvals.
Our team consists of experienced regulatory affairs professionals with deep knowledge of FDA requirements, inspection protocols, and approval pathways. We've successfully guided dozens of products through FDA registration and post-market compliance.
From initial regulatory strategy through post-approval management, we provide integrated solutions that simplify your compliance journey. One trusted partner means better coordination, faster resolution, and predictable outcomes.
We analyze your product profile, competitive landscape, and market goals to recommend optimal regulatory pathways. Strategic planning early in development saves time, reduces costs, and maximizes approval probability.
Every submission undergoes rigorous quality checks to ensure FDA compliance, technical accuracy, and compelling presentation. Our attention to detail has consistently resulted in favorable FDA decisions and rapid approvals.
We deliver high-quality regulatory services with transparent pricing and no hidden fees. Our efficient processes and resource optimization provide excellent value without compromising quality or compliance.
Your success doesn't end with approval. We provide ongoing support for variations, compliance maintenance, post-market surveillance, and future product development initiatives.
Our FDA regulatory expertise spans multiple healthcare sectors, each with unique requirements and challenges.
Expert guidance for small molecule drugs, including NDAs, ANDAs, INDs, and post-approval compliance. We navigate complex chemical and pharmaceutical requirements for accelerated US market entry.
Specialized BLA support for biologic drugs, therapeutic proteins, and biosimilar products. Our expertise includes CMC requirements, analytical methods, and clinical pathway optimization for biologics.
Comprehensive 510(k), PMA, and De Novo support for Class I, II, and III medical devices. We streamline device clearance and approval processes for faster US market access.
Specialized regulatory strategy for combination products. We navigate complex jurisdictional issues and optimize submission pathways for innovative combination therapies.
Strategic guidance on FDA requirements for dietary supplements and nutraceutical products, including NDI notifications and compliance management.
Expert support navigating the drug-cosmetic borderline. We help optimize product positioning and ensure full compliance with FDA cosmetic and drug regulations.
Complete NDA preparation and submission support for small molecule pharmaceuticals. We optimize dossier structure, address FDA questions, and guide you through the entire review process.
Specialized BLA services for recombinant proteins, monoclonal antibodies, vaccines, and cell-based therapies. We ensure comprehensive CMC, nonclinical, and clinical data packages.
Expert IND submission support to initiate clinical research in the US. We prepare detailed chemistry, manufacturing, controls (CMC), and safety data packages for rapid FDA authorization.
Strategic ANDA guidance for generic drug manufacturers, including bioequivalence strategy, patent certification, and market exclusivity analysis.
Streamlined 510(k) submissions including predicate device selection, substantial equivalence assessment, and performance testing. We minimize review cycles and accelerate clearance timelines.
Comprehensive Premarket Approval (PMA) and De Novo applications for high-risk medical devices. We develop compelling safety and efficacy packages that address FDA concerns.
Strategic support for expedited approval pathways. We assess eligibility, prepare compelling designation applications, and leverage accelerated review benefits for faster market entry.
Expert guidance on CBE, PAS, and PIND submissions for manufacturing changes, chemistry updates, and process improvements. We ensure compliance while maintaining market availability.
Let MedWisdom's expert regulatory team guide you through every phase of US market entry. From strategic planning to post-approval compliance, we're your trusted partner in FDA success.
Schedule Your Free FDA Strategy ConsultationTimeline varies significantly by product type and review priority. Standard NDAs average 10-14 months (PDUFA), while Priority Reviews take 6 months. eCTD submissions can reduce review timelines by 20-30%. Our strategic planning helps maximize approval speed.
An eCTD (electronic Common Technical Document) is the FDA-mandated format for regulatory submissions. It replaces paper submissions with structured electronic files, improving FDA reviewer efficiency and often accelerating approvals. We ensure your eCTD meets all FDA technical requirements.
Yes. Our team provides regulatory services across Asia, Europe, Middle East, Africa, and Americas. We coordinate multi-market strategies that leverage US approval timelines and data packages for global success.
Costs vary based on product complexity, submission type, and service scope. We offer transparent pricing with customized packages. Contact us for detailed project assessment and cost estimates.
Absolutely. We provide ongoing pharmacovigilance, adverse event monitoring, post-approval variations, compliance audits, and regulatory maintenance support to ensure sustained market success.
We assess your product's eligibility based on unmet medical need and preliminary efficacy data. If qualified, we prepare and submit compelling designation applications to position your product for expedited FDA review.
Join leading pharmaceutical and medical device companies that trust MedWisdom for expert FDA regulatory support. Accelerate your US market entry with proven expertise, strategic planning, and unwavering commitment to compliance.
Contact Our FDA Experts Now